2011
DOI: 10.1167/iovs.10-6522
|View full text |Cite
|
Sign up to set email alerts
|

Engagement of TLR2 Reverses the Suppressor Function of Conjunctiva CD4+CD25+Regulatory T Cells and Promotes Herpes Simplex Virus Epitope-Specific CD4+CD25Effector T Cell Responses

Abstract: PURPOSE. The authors recently reported that Foxp3(+)CD4(+) CD25(+(Bright)) "natural" regulatory T cells (nT(reg) cells) are abundant in rabbit conjunctiva and suppress herpes simplex virus (HSV)-1-specific CD4(+) and CD8(+) effector T cells (T(eff) cells). However, little is known about the overall regulatory mechanisms of these nT(reg) cells. The authors investigate the regulation of conjunctiva-resident nT(reg) cells through Toll-like receptors (TLRs) and their effect on ocular mucosal T(eff) cell immunity. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
19
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 17 publications
(20 citation statements)
references
References 79 publications
1
19
0
Order By: Relevance
“…We choose the Nε-palmitic acidlysine residue (a TLR-2 ligand) to better target the ASYMP CD4-CD8 peptide vaccine to the local ocular mucosal immune system, since, as shown in Fig. 2C and D, high levels of Toll-like receptor 2 (TLR-2), but not Toll-like receptor 4 (TLR-4), were expressed by rabbit cornea-and conjunctiva-derived CD11b/c ϩ antigen-presenting cells (APCs) (26). The final three TLR-2 ligand-peptide conjugate constructs (i.e., CD4-CD8 lipopeptide vaccines) were made using a chemoselective ligation method (25), which provides higher yield, purity, and solubility than the traditional method of lipopeptide synthesis.…”
Section: Construction Of Hsv-1 Cd4-cd8 Lipopeptide Vaccines Bearing Hmentioning
confidence: 99%
“…We choose the Nε-palmitic acidlysine residue (a TLR-2 ligand) to better target the ASYMP CD4-CD8 peptide vaccine to the local ocular mucosal immune system, since, as shown in Fig. 2C and D, high levels of Toll-like receptor 2 (TLR-2), but not Toll-like receptor 4 (TLR-4), were expressed by rabbit cornea-and conjunctiva-derived CD11b/c ϩ antigen-presenting cells (APCs) (26). The final three TLR-2 ligand-peptide conjugate constructs (i.e., CD4-CD8 lipopeptide vaccines) were made using a chemoselective ligation method (25), which provides higher yield, purity, and solubility than the traditional method of lipopeptide synthesis.…”
Section: Construction Of Hsv-1 Cd4-cd8 Lipopeptide Vaccines Bearing Hmentioning
confidence: 99%
“…An increasing number of studies had shown that TLRs are expressed by a variety of tissues and cells in the eye [10], [26]. However, whether retinal Muller glia express various TLRs is not known.…”
Section: Discussionmentioning
confidence: 99%
“…Upon cutaneous HSV-1 infection, K14-RANKL TG mice showed reduced disease severity as compared with WT controls, possibly suggesting that the infection might have impaired the RANKLmediated expansion of functional Treg. This hypothesis was supported by studies demonstrating that, during infection, Tregs frequently lose their suppressive activity in response to upregulated TLR signaling (Dasgupta et al, 2001;Peng et al, 2005;Zhang et al, 2010;Hackl et al, 2011). However, although we detected increased levels of various TLRs, such as TLR2, TLR7, and TLR9, in infected skin from TG mice (Klenner, unpublished observation), in vitro suppression assays revealed that Tregs from HSV-1-infected WT and TG mice inhibited the proliferation of effector T cells equally well, indicating that a potential loss of Treg function has a minor role in explaining the reduced disease severity in HSV-1-infected K14-RANKL TG mice.…”
Section: Discussionmentioning
confidence: 82%